{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T17:35:16Z","timestamp":1777138516564,"version":"3.51.4"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004263","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado do Rio Grande do Sul","doi-asserted-by":"publisher","award":["21\/2551\u20130000728-1"],"award-info":[{"award-number":["21\/2551\u20130000728-1"]}],"id":[{"id":"10.13039\/501100004263","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004263","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado do Rio Grande do Sul","doi-asserted-by":"publisher","award":["21\/2551\u20130000614-5"],"award-info":[{"award-number":["21\/2551\u20130000614-5"]}],"id":[{"id":"10.13039\/501100004263","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain Research"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.brainres.2024.148904","type":"journal-article","created":{"date-parts":[[2024,3,30]],"date-time":"2024-03-30T16:04:13Z","timestamp":1711814653000},"page":"148904","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["1-(Phenylselanyl)-2-(p-tolyl)indolizine: A selenoindolizine with potential antidepressant-like activity in mice mediated by the modulation of dopaminergic and noradrenergic systems"],"prefix":"10.1016","volume":"1834","author":[{"given":"Marcia Juciele","family":"da Rocha","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcelo Heinemann","family":"Presa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gustavo D'Avila","family":"Nunes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Narryman Pinto","family":"Zuge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camila Sim\u00f5es","family":"Pires","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evelyn Mianes","family":"Besckow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline Signorini","family":"Gomes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luiz Henrique","family":"Dapper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eder Jo\u00e3o","family":"Lenard\u00e3o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Filipe","family":"Penteado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristiani Folharini","family":"Bortolatto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C\u00e9sar Augusto","family":"Br\u00fcning","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.brainres.2024.148904_b0005","doi-asserted-by":"crossref","first-page":"839","DOI":"10.3892\/mmr.2021.12479","article-title":"Mental depression: relation to different disease status, newer treatments and its association with COVID-19 pandemic (review)","volume":"24","author":"Abdel-Bakky","year":"2021","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.brainres.2024.148904_b0010","unstructured":"Alhayek, S., Preuss, C.V., 2023. Beta 1 Receptors. StatPearls. Treasure Island (FL) ineligible companies. Disclosure: Charles Preuss declares no relevant financial relationships with ineligible companies."},{"issue":"21","key":"10.1016\/j.brainres.2024.148904_b0015","doi-asserted-by":"crossref","first-page":"7349","DOI":"10.3390\/molecules28217349","article-title":"Recent advances in the synthesis and antioxidant activity of low molecular mass organoselenium molecules","volume":"28","author":"Anghinoni","year":"2023","journal-title":"Molecules"},{"issue":"12","key":"10.1016\/j.brainres.2024.148904_b0020","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1093\/ijnp\/pyx056","article-title":"Dopamine system dysregulation in major depressive disorders","volume":"20","author":"Belujon","year":"2017","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.brainres.2024.148904_b0025","doi-asserted-by":"crossref","unstructured":"Bhawna, Kumar, A., Bhatia, M., Kapoor, A., Kumar, P., Kumar, S., 2022. Monoamine oxidase inhibitors: A concise review with special emphasis on structure activity relationship studies. Eur. J. Med. Chem. 242, 114655. https:\/\/doi.org\/10.1016\/j.ejmech.2022.114655.","DOI":"10.1016\/j.ejmech.2022.114655"},{"issue":"21","key":"10.1016\/j.brainres.2024.148904_b0030","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.2174\/0929867329666220615124412","article-title":"Neuropharmacology of organoselenium compounds in mental disorders and degenerative diseases","volume":"30","author":"Birmann","year":"2023","journal-title":"Curr. Med. Chem."},{"issue":"6","key":"10.1016\/j.brainres.2024.148904_b0035","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1111\/bph.15753","article-title":"Novel drug developmental strategies for treatment-resistant depression","volume":"179","author":"Borb\u00e9ly","year":"2022","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.brainres.2024.148904_b0040","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal. Biochem."},{"issue":"2","key":"10.1016\/j.brainres.2024.148904_b0045","doi-asserted-by":"crossref","first-page":"246","DOI":"10.3390\/brainsci12020246","article-title":"Role of stress-related dopamine transmission in building and maintaining a protective cognitive reserve","volume":"12","author":"Cabib","year":"2022","journal-title":"Brain Sci."},{"issue":"8","key":"10.1016\/j.brainres.2024.148904_b0050","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1177\/0269881113480988","article-title":"Noradrenergic modulation of cognition: therapeutic implications","volume":"27","author":"Chamberlain","year":"2013","journal-title":"J. Psychopharmacol."},{"issue":"10312","key":"10.1016\/j.brainres.2024.148904_b0055","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1016\/S0140-6736(21)02143-7","article-title":"Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic","volume":"398","author":"Collaborators","year":"2021","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.brainres.2024.148904_b0060","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s00213-023-06313-x","article-title":"Involvement of the serotonergic system in the antidepressant-like effect of 1-(phenylselanyl)-2-(p-tolyl)indolizine in mice","volume":"240","author":"da Rocha","year":"2023","journal-title":"Psychopharmacology (Berl)"},{"issue":"9","key":"10.1016\/j.brainres.2024.148904_b0065","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1080\/13543776.2020.1798402","article-title":"Inhibitory activities of indolizine derivatives: a patent review","volume":"30","author":"Dawood","year":"2020","journal-title":"Expert Opin. Ther. Pat."},{"issue":"9\u201311","key":"10.1016\/j.brainres.2024.148904_b0070","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.lfs.2013.07.024","article-title":"Involvement of the dopaminergic and serotonergic systems in the antidepressant-like effect caused by 4-phenyl-1-(phenylselanylmethyl)-1,2,3-triazole","volume":"93","author":"Donato","year":"2013","journal-title":"Life Sci."},{"issue":"2","key":"10.1016\/j.brainres.2024.148904_b0075","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0021-9258(18)84756-1","article-title":"The colorimetric determination of phosphorus","volume":"66","author":"Fiske","year":"1925","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.brainres.2024.148904_b0080","doi-asserted-by":"crossref","unstructured":"Garcia, C.S., Besckow, E.M., da Silva Esp\u00edndola, C.N., D'Avila Nunes, G., Zuge, N.P., de Azeredo, M.P., Rocha, M.J.D., Carraro Junior, L.R., Penteado, F., Gomes, C.S., Lenard\u00e3o, E.J., Bortolatto, C.F., Br\u00fcning, C.A., 2022. Antidepressant-Like Effect of a Selenoindolizine in Mice: In Vivo and In Silico Evidence for the Involvement of the Serotonergic 5-HT2A\/CReceptors. ACS Chem. Neurosci. 13 (12), 1746-1755. https:\/\/doi.org\/10.1021\/acschemneuro.2c00129.","DOI":"10.1021\/acschemneuro.2c00129"},{"issue":"24","key":"10.1016\/j.brainres.2024.148904_b0085","doi-asserted-by":"crossref","first-page":"9532","DOI":"10.3390\/ijms21249532","article-title":"Mechanism of action of atypical antipsychotic drugs in mood disorders","volume":"21","author":"Grinchii","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.brainres.2024.148904_b0090","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1758-2946-4-17","article-title":"Avogadro: an advanced semantic chemical editor, visualization, and analysis platform","volume":"4","author":"Hanwell","year":"2012","journal-title":"J. Cheminform."},{"issue":"1","key":"10.1016\/j.brainres.2024.148904_b0095","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/s41398-021-01682-3","article-title":"Expectancy effects on serotonin and dopamine transporters during SSRI treatment of social anxiety disorder: a randomized clinical trial","volume":"11","author":"Hjorth","year":"2021","journal-title":"Transl. Psychiatry"},{"issue":"2","key":"10.1016\/j.brainres.2024.148904_b0100","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/ijnp\/pyy081","article-title":"Circuit mechanisms of reward, anhedonia, and depression","volume":"22","author":"H\u00f6flich","year":"2019","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"4","key":"10.1016\/j.brainres.2024.148904_b0105","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/nn.4245","article-title":"Resilience to chronic stress is mediated by noradrenergic regulation of dopamine neurons","volume":"19","author":"Isingrini","year":"2016","journal-title":"Nat. Neurosci."},{"issue":"2","key":"10.1016\/j.brainres.2024.148904_b0110","doi-asserted-by":"crossref","first-page":"533","DOI":"10.3390\/molecules27020533","article-title":"Novel molecular targets of antidepressants","volume":"27","author":"Jaro\u0144czyk","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.brainres.2024.148904_b0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2022.104578","article-title":"Treatment-resistant depression with anhedonia: integrating clinical and preclinical approaches to investigate distinct phenotypes","volume":"136","author":"Kelly","year":"2022","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"1","key":"10.1016\/j.brainres.2024.148904_b0120","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s10571-018-0632-3","article-title":"Dopamine: functions, signaling, and association with neurological diseases","volume":"39","author":"Klein","year":"2019","journal-title":"Cell. Mol. Neurobiol."},{"issue":"11","key":"10.1016\/j.brainres.2024.148904_b0125","doi-asserted-by":"crossref","first-page":"9482","DOI":"10.3390\/ijms24119482","article-title":"Towards novel potential molecular targets for antidepressant and antipsychotic pharmacotherapies","volume":"24","author":"Kositsyn","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"11","key":"10.1016\/j.brainres.2024.148904_b0130","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1016\/0006-2952(65)90025-0","article-title":"A rapid microfluorimetric determination of monoamine oxidase","volume":"14","author":"Krajl","year":"1965","journal-title":"Biochem. Pharmacol."},{"issue":"6","key":"10.1016\/j.brainres.2024.148904_b0135","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1042\/ETLS20190061","article-title":"Animal experimentation: implementation and application of the 3Rs","volume":"3","author":"Lewis","year":"2019","journal-title":"Emerg Top Life Sci."},{"key":"10.1016\/j.brainres.2024.148904_b0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2020.108237","article-title":"SNRIs achieve faster antidepressant effects than SSRIs by elevating the concentrations of dopamine in the forebrain","volume":"177","author":"Li","year":"2020","journal-title":"Neuropharmacology"},{"issue":"4","key":"10.1016\/j.brainres.2024.148904_b0145","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/j.pnpbp.2008.01.012","article-title":"Involvement of the adenosine A1 and A2A receptors in the antidepressant-like effect of zinc in the forced swimming test","volume":"32","author":"Lobato","year":"2008","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"4","key":"10.1016\/j.brainres.2024.148904_b0150","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.3390\/ijms23042360","article-title":"Immunomodulatory and anti-inflammatory properties of selenium-containing agents: their role in the regulation of defense mechanisms against COVID-19","volume":"23","author":"Mal'tseva","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.brainres.2024.148904_b0155","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.2147\/DDDT.S46849","article-title":"Efficacy, tolerability, and acceptability of bupropion for major depressive disorder: a meta-analysis of randomized-controlled trials comparison with venlafaxine","volume":"7","author":"Maneeton","year":"2013","journal-title":"Drug Des. Devel. Ther."},{"issue":"1","key":"10.1016\/j.brainres.2024.148904_b0160","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0003-2697(84)90780-2","article-title":"3-(p-hydroxyphenyl)propionic acid as a new fluorogenic reagent for amine oxidase assays","volume":"138","author":"Matsumoto","year":"1984","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.brainres.2024.148904_b0165","doi-asserted-by":"crossref","unstructured":"McCarron, R.M., Shapiro, B., Rawles, J., Luo, J., 2021. Depression. Ann. Intern. Med. 174 (5), ITC65-ITC80. https:\/\/doi.org\/10.7326\/AITC202105180.","DOI":"10.7326\/AITC202105180"},{"key":"10.1016\/j.brainres.2024.148904_b0170","doi-asserted-by":"crossref","first-page":"541","DOI":"10.2147\/NDT.S91311","article-title":"The noradrenergic paradox: implications in the management of depression and anxiety","volume":"12","author":"Montoya","year":"2016","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.brainres.2024.148904_b0175","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.brainres.2024.148904_b0180","unstructured":"National Research Council (US) Committee for the Update of the Guide for the Care and Use of Laboratory Animals. 2011. Guide for the Care and Use of Laboratory Animals. 8th ed. Washington (DC): National Academies Press (US). PMID: 21595115."},{"key":"10.1016\/j.brainres.2024.148904_b0185","doi-asserted-by":"crossref","first-page":"1076799","DOI":"10.3389\/fnmol.2022.1076799","article-title":"Guanylyl cyclase\/natriuretic peptide receptor-a: identification, molecular characterization, and physiological genomics","volume":"15","author":"Pandey","year":"2022","journal-title":"Front. Mol. Neurosci."},{"issue":"2","key":"10.1016\/j.brainres.2024.148904_b0190","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1177\/2045125316629071","article-title":"Bupropion: a systematic review and meta-analysis of effectiveness as an antidepressant","volume":"6","author":"Patel","year":"2016","journal-title":"Ther. Adv. Psychopharmacol."},{"issue":"11","key":"10.1016\/j.brainres.2024.148904_b0195","doi-asserted-by":"crossref","first-page":"7189","DOI":"10.1021\/acs.joc.9b00871","article-title":"Regioselective synthesis of 1-sulfanyl- and 1-selanylindolizines","volume":"84","author":"Penteado","year":"2019","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.brainres.2024.148904_b0200","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF Chimera\u2013a visualization system for exploratory research and analysis","volume":"25","author":"Pettersen","year":"2004","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.brainres.2024.148904_b0205","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.pnpbp.2015.10.008","article-title":"Involvement of monoaminergic system in the antidepressant-like effect of (octylseleno)-xylofuranoside in the mouse tail suspension test","volume":"65","author":"Pinto Brod","year":"2016","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"2","key":"10.1016\/j.brainres.2024.148904_b0210","first-page":"327","article-title":"Behavioral despair in mice: a primary screening test for antidepressants","volume":"229","author":"Porsolt","year":"1977","journal-title":"Arch. Int. Pharmacodyn. Ther."},{"issue":"5","key":"10.1016\/j.brainres.2024.148904_b0215","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1002\/med.21671","article-title":"New-generation, non-SSRI antidepressants: drug-drug interactions and therapeutic drug monitoring. Part 2: NaSSAs, NRIs, SNDRIs, MASSAs, NDRIs, and others","volume":"40","author":"Protti","year":"2020","journal-title":"Med. Res. Rev."},{"issue":"11","key":"10.1016\/j.brainres.2024.148904_b0220","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1007\/s00702-018-1861-9","article-title":"Kinetics, mechanism, and inhibition of monoamine oxidase","volume":"125","author":"Ramsay","year":"2018","journal-title":"J. Neural Transm. (Vienna)"},{"issue":"10","key":"10.1016\/j.brainres.2024.148904_b0225","doi-asserted-by":"crossref","first-page":"3013","DOI":"10.1007\/s00213-021-05921-9","article-title":"2-Phenyl-3-(phenylselanyl)benzofuran elicits acute antidepressant-like action in male Swiss mice mediated by modulation of the dopaminergic system and reveals therapeutic efficacy in both sexes","volume":"238","author":"Rech","year":"2021","journal-title":"Psychopharmacology (Berl)"},{"issue":"4","key":"10.1016\/j.brainres.2024.148904_b0230","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1055\/a-1714-9097","article-title":"Novel antidepressants in the pipeline (phase II and III): a systematic review of the US clinical trials registry","volume":"55","author":"Sakurai","year":"2022","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.brainres.2024.148904_b0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2020.112602","article-title":"Dopaminergic system contribution to the antidepressant-like effect of 3-phenyl-4-(phenylseleno) isoquinoline in mice","volume":"386","author":"Sampaio","year":"2020","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.brainres.2024.148904_b0240","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1073\/pnas.2237265100","article-title":"The second extracellular loop of the dopamine D2 receptor lines the binding-site crevice","volume":"101","author":"Shi","year":"2004","journal-title":"PNAS"},{"issue":"11","key":"10.1016\/j.brainres.2024.148904_b0245","doi-asserted-by":"crossref","first-page":"5237","DOI":"10.1016\/j.ejmech.2011.08.042","article-title":"Recent progress in synthesis and bioactivity studies of indolizines","volume":"46","author":"Singh","year":"2011","journal-title":"Eur. J. Med. Chem."},{"issue":"22","key":"10.1016\/j.brainres.2024.148904_b0250","doi-asserted-by":"crossref","first-page":"8997","DOI":"10.1021\/acs.orglett.9b03402","article-title":"Synthesis of indolizine and Pyrrolo[1,2-a]azepine derivatives via a Gold(I)-catalyzed three-step cascade","volume":"21","author":"Sirindil","year":"2019","journal-title":"Org. Lett."},{"issue":"8","key":"10.1016\/j.brainres.2024.148904_b0255","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/S0024-3205(01)01178-X","article-title":"Inhibition of brain monoamine oxidase activity by the generation of hydroxyl radicals: potential implications in relation to oxidative stress","volume":"69","author":"Soto-Otero","year":"2001","journal-title":"Life Sci."},{"key":"10.1016\/j.brainres.2024.148904_b0260","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.988648","article-title":"The treatment of depression - searching for new ideas","volume":"13","author":"Stachowicz","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.brainres.2024.148904_b0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2023.110772","article-title":"Depressive-like behavior and cognitive impairment induced by acute administration of dexamethasone: Pharmacological effects of 2-phenyl-3-(phenylselanyl)benzofuran in female Swiss mice","volume":"125","author":"Strelow","year":"2023","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.brainres.2024.148904_b0270","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/j.jad.2021.01.021","article-title":"Revisiting monoamine oxidase inhibitors for the treatment of depressive disorders: a systematic review and network meta-analysis","volume":"282","author":"Suchting","year":"2021","journal-title":"J. Affect. Disord."},{"issue":"7","key":"10.1016\/j.brainres.2024.148904_b0275","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1007\/s00894-017-3363-3","article-title":"Potential inhibitory effect of indolizine derivatives on the two enzymes: nicotinamide phosphoribosyltransferase and beta lactamase, a molecular dynamics study","volume":"23","author":"Szefler","year":"2017","journal-title":"J. Mol. Model."},{"key":"10.1016\/j.brainres.2024.148904_b0280","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J. Comput. Chem."},{"issue":"6","key":"10.1016\/j.brainres.2024.148904_b0285","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1134\/S0006297921060146","article-title":"Monoamine oxidase as a potential biomarker of the efficacy of treatment of mental Disorders","volume":"86","author":"Uzbekov","year":"2021","journal-title":"Biochemistry (Mosc)."},{"key":"10.1016\/j.brainres.2024.148904_b0290","first-page":"1","article-title":"The prescriber's guide to classic MAO inhibitors (phenelzine, tranylcypromine, isocarboxazid) for treatment-resistant depression","volume":"15","author":"Van den Eynde","year":"2022","journal-title":"CNS Spectr."},{"issue":"5","key":"10.1016\/j.brainres.2024.148904_b0295","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1093\/jpp\/rgaa070","article-title":"A selanylimidazopyridine (3-SePh-IP) reverses the prodepressant- and anxiogenic-like effects of a high-fat\/high-fructose diet in mice","volume":"73","author":"Veloso","year":"2021","journal-title":"J. Pharm. Pharmacol."},{"issue":"3","key":"10.1016\/j.brainres.2024.148904_b0300","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1037\/0033-2909.83.3.482","article-title":"The open-field test: a critical review","volume":"83","author":"Walsh","year":"1976","journal-title":"Psychol. Bull."},{"key":"10.1016\/j.brainres.2024.148904_b0305","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2023.109691","article-title":"Phosphorylated Ser187-SNAP25-modulated hyperfunction of glutamatergic system in the vmPFC mediates depressive-like behaviors in male mice","volume":"239","author":"Wang","year":"2023","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.brainres.2024.148904_b0310","unstructured":"World Health Organization, 2023. Depressive disorder (depression). https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/depression (accessed 13 September 2023)."},{"issue":"11","key":"10.1016\/j.brainres.2024.148904_b0315","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1007\/s00702-018-1942-9","article-title":"Monoamine oxidase inhibitors, and iron chelators in depressive illness and neurodegenerative diseases","volume":"125","author":"Youdim","year":"2018","journal-title":"J. Neural Transm. (Vienna)"},{"issue":"16","key":"10.1016\/j.brainres.2024.148904_b0320","doi-asserted-by":"crossref","first-page":"10719","DOI":"10.1021\/acs.joc.0c01253","article-title":"Synthesis of Pyrrolo[2,1,5-cd]indolizine rings via visible-light-induced intermolecular [3+2] cycloaddition of indolizines and alkynes","volume":"85","author":"Zhang","year":"2020","journal-title":"J. Org. Chem."},{"issue":"4","key":"10.1016\/j.brainres.2024.148904_b0325","doi-asserted-by":"crossref","first-page":"597","DOI":"10.3390\/biom12040597","article-title":"Cerebral glutamate regulation and receptor changes in perioperative neuroinflammation and cognitive dysfunction","volume":"12","author":"Zhang","year":"2022","journal-title":"Biomolecules"},{"issue":"4","key":"10.1016\/j.brainres.2024.148904_b0330","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.cell.2021.01.027","article-title":"Structural insights into the human D1 and D2 dopamine receptor signaling complexes","volume":"184","author":"Zhuang","year":"2021","journal-title":"Cell"}],"container-title":["Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899324001586?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899324001586?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,8]],"date-time":"2024-05-08T01:02:37Z","timestamp":1715130157000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006899324001586"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":66,"alternative-id":["S0006899324001586"],"URL":"https:\/\/doi.org\/10.1016\/j.brainres.2024.148904","relation":{},"ISSN":["0006-8993"],"issn-type":[{"value":"0006-8993","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"1-(Phenylselanyl)-2-(p-tolyl)indolizine: A selenoindolizine with potential antidepressant-like activity in mice mediated by the modulation of dopaminergic and noradrenergic systems","name":"articletitle","label":"Article Title"},{"value":"Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brainres.2024.148904","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"148904"}}